Program notes:

0:37 Breast density knowledge outcomes

1:37 Breast density notification and education

2:37 Can't assess the import individually

3:30 CV outcomes with tirzepatide

4:30 HbA1c 8.4

5:30 GLP-1s have many benefits

6:30 No difference in adverse events

7:10 Covid vaccination in pregnancy

8:10 20K women included

9:10 Initial benefit is it durable?

9:30 Complex regional pain syndrome treatment

10:30 Using bisphosphonates for treatment

11:33 Even light contact causes severe pain

12:28 End